| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| R&D Expense | $622K | +4.7% |
| SG&A Expense | $1.7M | -13.8% |
| Operating Income | -$2.4M | +9.6% |
| Pre-tax Income | -$2.3M | +26.1% |
| Net Income | -$2.3M | +34.7% |
| EPS (Basic) | -$0.04 | +33.3% |
| EPS (Diluted) | -$0.04 | +33.3% |
| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.6M | +424.7% |
| Short-term Investments | $3.0M | +0.0% |
| Current Assets | $6.6M | +32.3% |
| Total Assets | $6.6M | +32.8% |
| Current Liabilities | $194K | -39.6% |
| Total Liabilities | $194K | -39.6% |
| Stockholders' Equity | $6.5M | +37.8% |
| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.5M | +13.7% |
| Capital Expenditures | $38K | +1832.7% |
| Investing Cash Flow | $3.0M | +18.6% |
| Financing Cash Flow | $3.8M | — |
| Free Cash Flow | -$1.5M | +11.6% |